WRAIR Begins Ebola Vaccine Phase 2 Trial
The Walter Reed Army Institute of Research (WRAIR) today announced the initiation of a Phase 2 clinical trial to evaluate ...
Tag: WRAIR
U.S. Army, Mongolia Cooperate on Influenza Studies
The U.S. Army has announced intentions to award a sole source contract to the National Center for Communicable Disease (NCCD), ...
Positive Safety, Efficacy Results for VSV-EBOV Ebola Vaccine
An early-stage clinical trial of an experimental Ebola vaccine called VSV-EBOV found that the vaccine is safe and elicited a ...
iBio Adds Anthrax Antibodies to Product Pipeline
iBio, Inc. today announced the issue of a US patent for “Compositions and Methods for Production of Immunoglobulins.” Claims involve ...
Pharmacological Studies of Anti-Parasitic Drugs
The U.S. Army Medical Research Acquisition Activity has awarded a new contract for continued research and development of anti-parasitic drugs. ...
Army Ovitrap Helps Prevent Mosquito-Borne Disease
It took more than 20 years, but a device invented by Army entomologists to control the population of mosquitoes that ...
NMRC Researchers Help Demonstrate Vaccine Protects Against Malaria
Researchers from the Naval Medical Research Center (NMRC) partnered with other federal and industry partners to publish the results of ...
Researchers Begin Trial of Shigella Vaccine Candidates
Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella. Antibiotics are ...
Army Moves Forward on Topical Drug for Cutaneous Leishmaniasis
The U.S. Army Medical Material Development Activity (USAMMDA) yesterday announced its intent to award a sole source contract to Fast ...
ClinicalRM Receives Military Medical Research Contract
Clinical Research Management, Inc. (ClinicalRM) was this week awarded a $597K contract by the U.S. Army Medical Research Acquisition Activity ...
